These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

68 related items for PubMed ID: 1540966

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Properties and function of nephrocalcin: mechanism of kidney stone inhibition or promotion.
    Nakagawa Y.
    Keio J Med; 1997 Mar; 46(1):1-9. PubMed ID: 9095576
    [Abstract] [Full Text] [Related]

  • 4. Role of nephrocalcin in inhibition of calcium oxalate crystallization and nephrolithiasis.
    Coe FL, Nakagawa Y, Asplin J, Parks JH.
    Miner Electrolyte Metab; 1994 Mar; 20(6):378-84. PubMed ID: 7783700
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Evidence that mouse renal proximal tubule cells produce nephrocalcin.
    Sirivongs D, Nakagawa Y, Vishny WK, Favus MJ, Coe FL.
    Am J Physiol; 1989 Sep; 257(3 Pt 2):F390-8. PubMed ID: 2782421
    [Abstract] [Full Text] [Related]

  • 7. Isolation from human calcium oxalate renal stones of nephrocalcin, a glycoprotein inhibitor of calcium oxalate crystal growth. Evidence that nephrocalcin from patients with calcium oxalate nephrolithiasis is deficient in gamma-carboxyglutamic acid.
    Nakagawa Y, Ahmed M, Hall SL, Deganello S, Coe FL.
    J Clin Invest; 1987 Jun; 79(6):1782-7. PubMed ID: 3584470
    [Abstract] [Full Text] [Related]

  • 8. Characterization of Ca(2+)-binding sites in the kidney stone inhibitor glycoprotein nephrocalcin using vanadyl ions: different metal binding properties in strong and weak inhibitor proteins revealed by EPR and ENDOR.
    Mustafi D, Nakagawa Y.
    Biochemistry; 1996 Nov 26; 35(47):14703-9. PubMed ID: 8942630
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Extensive calcium oxalate crystal deposition in papillary renal cell carcinoma: report of two cases.
    Dry SM, Renshaw AA.
    Arch Pathol Lab Med; 1998 Mar 26; 122(3):260-1. PubMed ID: 9823865
    [Abstract] [Full Text] [Related]

  • 11. Isolation of nephrocalcin from kidney tissue of nine vertebrate species.
    Nakagawa Y, Renz CL, Ahmed M, Coe FL.
    Am J Physiol; 1991 Feb 26; 260(2 Pt 2):F243-8. PubMed ID: 1996674
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Calponin h1 expression in renal tumor vessels: correlations with multiple pathological factors of renal cell carcinoma.
    Islam AH, Ehara T, Kato H, Hayama M, Kobayashi S, Igawa Y, Nishizawa O.
    J Urol; 2004 Mar 26; 171(3):1319-23. PubMed ID: 14767341
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. [Role of organ specific fibroblasts in metastasis of human renal cell carcinoma: regulation of type IV collagenase production from human renal cell carcinoma by organ specific fibroblasts].
    Gohji K, Kamidono S.
    Hinyokika Kiyo; 1994 Oct 26; 40(10):909-17. PubMed ID: 7992708
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Identification of stanniocalcin 2 as prognostic marker in renal cell carcinoma.
    Meyer HA, Tölle A, Jung M, Fritzsche FR, Haendler B, Kristiansen I, Gaspert A, Johannsen M, Jung K, Kristiansen G.
    Eur Urol; 2009 Mar 26; 55(3):669-78. PubMed ID: 18450365
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.